Ashneer Grover criticizes PharmEasy’s plan to raise $300 million, calls it ‘The end’
He said that a 'down round' with a combination of 'anti-dilutive clause' would result in "sudden death" of the founders.
PharmEasy
Stay updated with the latest news and articles about PharmEasy.
Latest Articles
SEBI approves PharmEasy parent, API Holdings for Rs 6,250 crore IPO
Firm that got the green flag was API Holdings Ltd, the parent of online pharmacy PharmEasy, Wellness Forever Medicare Ltd and CMR Green Technologies Ltd.
PharmEasy to file DRHP with SEBI in October to raise funds by IPO: Report
Earlier this month, it was reported that PharmEasy was aiming to raise $9 billion through the IPO. In July, SoftBank Group was in talks with PharmEasy’s parent company API Holding’s for investment. According to sources, the discussion did not materialize.
PharmEasy aims to raise $9 billion via IPO
“The entire proceeds of the listing will be used to pursue growth opportunities," one of the sources told LiveMint. Prosus Ventures, TPG Growth, CDPQ and Temasek are among PharmEasy’s top investors.
PharmEasy looks forward to acquiring 66.1% stake in Thyrocare for Rs 4,546 crore
PharmEasy for Rs 4,546 crore, plans to acquire 66.1% stake in Thyrocare.